🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of next-day British shipping. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to users injecting products of unknown origin.

Some professionals said the demand for the experimental drug could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the platform has taken down violative material and prohibited associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also discovered communities with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of weight loss, positive testimonials and detailed guides for mixing or administering at residence.

After minutes of entering one community, a seller posted contact information, where most transactions take place. The vendor provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or past usage.

Item Details and Costs

Within these groups, messages show black plastic packages with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When asked how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to potentially significant health risks”.